Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Swelling attacks occurring in patients taking ACE inhibitors or AT-1 blockers are also mediated by bradykinin. This is because these medications inhibit the break-down of bradykinin, leading to an increase in the bradykinin concentration followed by increased permeability of the vascular wall and, sometimes, the development of angioedema.
